Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_19-cv-02380/USCOURTS-caed-2_19-cv-02380-0/pdf.json

Nature of Suit Code: 367
Nature of Suit: TORTS - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability
Cause of Action: 28:1332 Diversity-Personal Injury

---

UNITED STATES JUDICIAL PANEL

on

MULTIDISTRICT LITIGATION

IN RE: ZANTAC (RANITIDINE) PRODUCTS

LIABILITY LITIGATION MDL No. 2924

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO í1)

On February 6, 2020, the Panel transferred 12 civil action(s) to the United States District Court for

the Southern District of Florida for coordinated or consolidated pretrial proceedings pursuant to 28

U.S.C. § 1407. See _F.Supp.3d_ (J.P.M.L. 2020). Since that time, no additional action(s) have been

transferred to the Southern District of Florida. With the consent of that court, all such actions have

been assigned to the Honorable Robin L. Rosenberg.

It appears that the action(s) on this conditional transfer order involve questions of fact that are

common to the actions previously transferred to the Southern District of Florida and assigned to

Judge Rosenberg.

Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict

Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the

Southern District of Florida for the reasons stated in the order of February 6, 2020, and, with the

consent of that court, assigned to the Honorable Robin L. Rosenberg.

This order does not become effective until it is filed in the Office of the Clerk of the United States

District Court for the Southern District of Florida. The transmittal of this order to said Clerk shall be

stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the

Panel within this 7íday period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

John W. Nichols

Clerk of the Panel

Feb 18, 2020

Patrick Edwards

Feb 19, 2020

FILED

Feb 21, 2020

CLERK, U.S. DISTRICT COURT

EASTERN DISTRICT OF CALIFORNIA

Case 2:19-cv-02380-KJM-EFB Document 20 Filed 02/21/20 Page 1 of 6
IN RE: ZANTAC (RANITIDINE) PRODUCTS

LIABILITY LITIGATION MDL No. 2924

SCHEDULE CTOí1 í TAGíALONG ACTIONS

DIST DIV. C.A.NO. CASE CAPTION

CALIFORNIA CENTRAL

CAC 2 19í09666 Howell Franklin v. Boehringer Ingelheim

Pharmaceuticals, Inc. et al

CAC 5 19í02161 Herbert Souza et al v. SanofiíAventis, U.S. LLC et al

CALIFORNIA EASTERN

CAE 2 19í02275 BrestíLandry v. Boehringer Ingelheim Pharmaceuticals,

Inc. et al

CAE 2 19í02380 Campu v. Boehringer Ingelheim Pharmaceuticals, Inc. et

al

CAE 2 20í00128 Johnson v. Boehringer Ingelheim Pharmaceuticals, Inc.

et al

CALIFORNIA SOUTHERN

CAS 3 19í02296 Hart v. Boehringer Ingelheim Pharmaceuticals, Inc. et al

FLORIDA MIDDLE

FLM 8 19í03085 Harris et al v. Boehringer Ingelheim Pharmaceuticals,

Inc. et al

FLORIDA NORTHERN

FLN 1 19í00329 CHASE v. SANOFI SA et al

FLN 3 19í04429 MCDONALD v. SANOFI S.A. et al

ILLINOIS NORTHERN

ILN 1 19í07773 White et al v. Glaxosmithkline plc et al

ILN 1 20í00454 Guy v. SanofiíAventis U.S. LLC et al

ILLINOIS SOUTHERN

ILS 3 19í01363 Chatman v. SanofiíAventis U.S., LLC, et al.

Case 2:19-cv-02380-KJM-EFB Document 20 Filed 02/21/20 Page 2 of 6
KYW 5 20í00011 Wamble v. Boehringer Ingelheim Pharmaceuticals, Inc.

et al

MASSACHUSETTS

MA 1 19í12471 Bond v. SanofiíAventis U.S., LLC et al

MINNESOTA

MN 0 19í03044 Scholl et al v. SanofiíAventis U.S. LLC et al

MISSISSIPPI NORTHERN

MSN 1 20í00009 McAnally v. SanofiíAventis U.S. LLC et al

MISSOURI WESTERN

MOW 6 19í03406 Rosenauer v. SanofiíAventis U.S. LLC et al

NEW JERSEY

NJ 3 19í20023 COLON v. SANOFIíAVENTIS U.S. LLC et al

NJ 3 19í20060 COGGINS et al v. SANOFIíAVENTIS U.S. LLC et al

NJ 3 19í20289 COMBS et al v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í20484 NEARY v. SANOFIíAVENTIS U.S. LLC et al

NJ 3 19í20621 PERONE v. BOEHRINGER INGELHEIM

PHARMACEUTICALS INC. et al

NJ 3 19í20645 DIAMANTE v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í20649 BOEKHOLT v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í20650 PINKNEY v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í20651 MCCANN v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í20908 KIGER v. CHATTEM, INC et al

NJ 3 19í20910 MOLINA v. BOEHRINGER INGELHEIM

PHARMACEUTICALS INC. et al

NJ 3 19í20911 RUTHERFORD v. BOEHRINGER INGELHEIM

PHARMACEUTICALS INC. et al

NJ 3 19í21142 BICE, JR. v. SANOFIíAVENTIS U.S. LLC et al

NJ 3 19í21199 BAZAN v. SANOFIíAVENTIS U.S. LLC et al

NJ 3 19í21206 JORDAN v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21207 MOORS v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21210 MICLE, SR. v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21323 SIMON v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

Case 2:19-cv-02380-KJM-EFB Document 20 Filed 02/21/20 Page 3 of 6
NJ 3 19í21324 ARIAS v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21326 CONQUEST v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21332 GAWLICK v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21334 JACQUET v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21512 BAKER v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21514 BEAN v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21517 EVERETT v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21518 GREEN v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21519 MACEACHERN v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21521 WYNN v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 19í21525 LINSON v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00029 ALVIAR v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00039 BELL v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00057 BRYANT v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00067 CARBAGAL v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00068 DAVIS v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00079 DAWSON v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00105 HASKINS v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00117 JOHNSON v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00125 LIEM v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00131 LOUBRIEL v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00134 LUTZ v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00136 MACKLEY v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00140 MARABLE v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00167 ROESSLER v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00171 ROSE v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

NJ 3 20í00176

Case 2:19-cv-02380-KJM-EFB Document 20 Filed 02/21/20 Page 4 of 6
NJ 3 20í00178

NJ 3 20í00385

NJ 3 20í00941

19í06376

NEW YORK EASTERN

NYE 1

NEW YORK SOUTHERN

NYS 1 19í10253

NYS 1 19í10935

NYS 1 19í11391

NYS 1 19í11515

NYS 1 19í11632

NYS 1 19í11944

NYS 1 20í00004

NYS 1 20í00527

NYS 1 20í00723

NORTH CAROLINA WESTERN

NCW 3 19í00628

OHIO NORTHERN

OHN 1 19í02729

OHN 1 19í02731

OHN 1 19í02852

OHN 1 20í00017

OHN 1 20í00040

OHN 1 20í00175

OHIO SOUTHERN

OHS 2 20í00356

WILKERSON v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

ZACEK v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

O'NEAL v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

PELLEGRENE et al v. SANOFI US SERVICES INC.

et al

Melillo v. SanofiíAventis U.S. LLC

Koppell et al v. Perrigo Company PLC et aO 2SSRVHG

Will v. Boehringer Ingelheim Pharmaceuticals, Inc. et al

Finer v. Boehringer Ingelheim Pharmaceuticals, Inc. et al

Chille v. Boehringer Ingelheim Pharmaceuticals, Inc. et

al

Froehlich v. SanofiíAventis U.S. LLC et al

Massiah v. SanofiíAventis U.S. LLC et al

Viola v. Pfizer Inc.

Swearingen v. SanofiíAventis U.S. LLC et al

Epting v. Boehringer Ingelheim Pharmaceuticals, Inc. et

al

Anthony v. Boehringer Ingelheim Pharmaceuticals, Inc.

et al

Vavra v. Boehringer Ingelheim Pharmaceuticals, Inc., et

al.

Payne v. Boehringer Ingelheim Pharmaceuticals, Inc., et

al.

Konn v. Boehringer Ingelheim Pharmaceuticals, Inc. et

al

Wells v. Boehringer Ingelheim Pharmaceuticals, Inc.,

etal

Carroll v. Boehringer Ingelheim Pharmaceuticals, Inc. et

al

Baker v. Boehringer Ingelheim Pharmaceuticals, Inc. et

al

Dodson et al v. Sanofi S.A et al

PENNSYLVANIA EASTERN

Case 2:19-cv-02380-KJM-EFB Document 20 Filed 02/21/20 Page 5 of 6
PAE 5 19í04824 FRANCIS v. BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC. et al

VERMONT

VT 2 19í00231 Ragis et al v. SanofiíAventis U.S., LLC et al

Case 2:19-cv-02380-KJM-EFB Document 20 Filed 02/21/20 Page 6 of 6